Marco l. davila
Deparment of Immunology
Moffitt Cancer Center
United States of America
Dr. Marco L. Davila is affiliated to Deparment of Immunology, Moffitt Cancer Center. Dr. Marco L. Davila is currently providing services as Researcher. Dr. Marco L. Davila has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Marco L. Davila contributions have acclaimed recognition from honourable subject experts around the world. Dr. Marco L. Davila is actively associated with different societies and academies. Dr. Marco L. Davila academic career is decorated with several reputed awards and funding. Dr. Marco L. Davila research interests include developing gene-engineered cell therapies that target cancer cells in animal models of cancer.
Developing gene-engineered cell therapies that target cancer cells in animal models of cancer
Sallman DA, Davila ML. Is Disease-Specific Immunotherapy a Potential Reality for MDS?. Clin Lymphoma Myeloma Leuk. 2017 Jul;17S:S26-S30.
Locke FL, Davila ML. Regulatory challenges and considerations for the clinical application of CAR-T cell anti-cancer therapy. Expert Opin Biol Ther. 2017 Jun;17(6):659-661.
Betts BC, Pidala J, Kim J, Mishra A, Nishihori T, Perez L, Ochoa-Bayona JL, Khimani F, Walton K, Bookout R, Nieder M, Khaira DK, Davila M, Alsina M, Field T, Ayala E, Locke FL, Riches M, Kharfan-Dabaja M, Fernandez H, Anasetti C. IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation. Haematologica. 2017 May;102(5):948-957.